OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 41 filers reported holding OPIANT PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,969 | -99.8% | 146,415 | -17.2% | 0.00% | +33.3% |
Q3 2022 | $1,902,000 | -18.0% | 176,915 | -8.5% | 0.00% | 0.0% |
Q2 2022 | $2,319,000 | -39.2% | 193,415 | +8.7% | 0.00% | -25.0% |
Q1 2022 | $3,813,000 | -38.3% | 178,015 | -3.2% | 0.00% | -50.0% |
Q4 2021 | $6,182,000 | +16.8% | 183,815 | -10.6% | 0.01% | +14.3% |
Q3 2021 | $5,293,000 | +106.9% | 205,615 | +7.5% | 0.01% | +133.3% |
Q2 2021 | $2,558,000 | +8.1% | 191,315 | -14.1% | 0.00% | 0.0% |
Q1 2021 | $2,366,000 | +24.4% | 222,815 | -5.9% | 0.00% | +50.0% |
Q4 2020 | $1,902,000 | +17.8% | 236,815 | +9.7% | 0.00% | 0.0% |
Q3 2020 | $1,615,000 | -4.8% | 215,915 | +14.9% | 0.00% | +100.0% |
Q2 2020 | $1,697,000 | +189.1% | 187,970 | +207.0% | 0.00% | 0.0% |
Q1 2020 | $587,000 | -0.7% | 61,228 | +49.2% | 0.00% | – |
Q4 2019 | $591,000 | +158.1% | 41,028 | +169.8% | 0.00% | – |
Q3 2019 | $229,000 | – | 15,209 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 210,000 | $2,518,000 | 5.80% |
APIS CAPITAL ADVISORS, LLC | 196,000 | $2,350,000 | 2.65% |
Stonepine Capital Management, LLC | 152,278 | $1,826,000 | 0.85% |
Parkman Healthcare Partners LLC | 75,632 | $907,000 | 0.33% |
PERRITT CAPITAL MANAGEMENT INC | 30,500 | $366,000 | 0.22% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 50,405 | $604,000 | 0.10% |
ACADIAN ASSET MANAGEMENT LLC | 126,978 | $1,523,000 | 0.01% |
Trexquant Investment LP | 12,219 | $147,000 | 0.01% |
Renaissance Technologies | 193,415 | $2,319,000 | 0.00% |
TWO SIGMA ADVISERS, LP | 74,400 | $892,000 | 0.00% |